secwatch.observer — SEC 8-K summary
======================================

Issuer:     WATERS CORP /DE/ (WAT)
CIK:        0001000697
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001193125-26-041897
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Waters Q4 2025 sales $932M (+7%), non-GAAP EPS $4.53 (+10%); BD deal closed; guides FY26 rev $6.4-6.5B, EPS $14.30-14.50
--------------------------------------------------------------------------------

- Q4 sales $932M (+7% reported, +6% CC); GAAP EPS $3.77, non-GAAP EPS $4.53 (+10% YoY).
- Q4 end-markets: Pharma +8%, Industrial +8%, Academic/Gov -2%; Instruments +3%, Recurring +10% (Chemistry +12% CC).
- Full-year 2025 sales $3,165M (+7%); non-GAAP EPS $13.13 (+11% YoY).
- Closes BD Biosciences & Diagnostic Solutions acquisition; acquired business adds ~$3.0B revenue in FY2026.
- FY2026 guidance: organic CC growth 5.5%-7.0%, total rev $6.405B-$6.455B; non-GAAP EPS $14.30-$14.50 (+8.9%-10.4% YoY).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000697/000119312526041897/0001193125-26-041897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000697/000119312526041897/d37473d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-041897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer